TRANSAMERICA LIFE INSURANCE COMPANY has sponsored the creation of one or more 401k plans.
| Measure | Date | Value |
|---|
| 2022 : MFS LIFETIME 2050 RET OPT 2022 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $-194,055 |
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $-194,055 |
| Total transfer of assets to this plan | 2022-12-31 | $813,474 |
| Total transfer of assets from this plan | 2022-12-31 | $185,367 |
| Total income from all sources (including contributions) | 2022-12-31 | $-123,200 |
| Value of total assets at end of year | 2022-12-31 | $1,132,019 |
| Value of total assets at beginning of year | 2022-12-31 | $627,112 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $28,817 |
| Value of net income/loss | 2022-12-31 | $-123,200 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $1,132,019 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $627,112 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $1,132,019 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $627,112 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $42,038 |
| Income. Dividends from common stock | 2022-12-31 | $28,817 |
| 2021 : MFS LIFETIME 2050 RET OPT 2021 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $7,594 |
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $7,594 |
| Total transfer of assets to this plan | 2021-12-31 | $405,875 |
| Total transfer of assets from this plan | 2021-12-31 | $7,798 |
| Total income from all sources (including contributions) | 2021-12-31 | $59,761 |
| Value of total assets at end of year | 2021-12-31 | $627,112 |
| Value of total assets at beginning of year | 2021-12-31 | $169,274 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $30,007 |
| Value of net income/loss | 2021-12-31 | $59,761 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $627,112 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $169,274 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $627,112 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $169,274 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $22,160 |
| Income. Dividends from common stock | 2021-12-31 | $30,007 |
| 2020 : MFS LIFETIME 2050 RET OPT 2020 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $30,701 |
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $30,701 |
| Total transfer of assets to this plan | 2020-12-31 | $158,568 |
| Total transfer of assets from this plan | 2020-12-31 | $24,008 |
| Total income from all sources (including contributions) | 2020-12-31 | $34,714 |
| Value of total assets at end of year | 2020-12-31 | $169,274 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $2,238 |
| Value of net income/loss | 2020-12-31 | $34,714 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $169,274 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $169,274 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $1,775 |
| Income. Dividends from common stock | 2020-12-31 | $2,238 |
Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.
See full terms and conditions
